Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-837-1 | CAS number: 7758-23-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
In the absence of specific data on the ADME of calcium bis (dihydrogenorthophosphate) (MCP), its physicochemical properties and relevant toxicity data (where available) were assessed for insights into likely ADME characteristics. MCP has a MW < 500 g/mol (235 g/mol) and is soluble in water. It is considered that absorption via oral route is likely to be moderate due to its nature to ionise into phosphate and calcium. Phosphate and calcium are important biological molecules which are tightly regulated systemically as well as intra-cellular. Absorption of MCP itself via inhalation route will be low due to its molecular weight. Non-resorbed particles in the oral-nasal cavity, airways and lungs will be transferred to the gastrointestinal tract with the mucus and absorbed there. Therefore, the absorption from the gastrointestinal tract will contribute to the total systemic burden of the substance that is inhaled. Low dermal absorption is expected. Based on a precautionary approach, an absorption default value of 100% is considered appropriate for oral and inhalation route and 50% for the dermal route. Wide tissue distribution of absorbed MCP itself is not expected, but the ionic forms of phosphate and calcium are widely distributed due to the indispensable character of phosphate and calcium. The suggested metabolism involves hydrolysis to the more soluble and polar products, calcium and phosphate ions. Due to these factors, urinary excretion as well as via faeces and sweat is the most probable route of elimination and bioaccumulation is unlikely.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
There are no studies available in which the toxicokinetic behaviour of calcium bis (dihydrogenorthophosphate) (CAS 7758-23-8) has been investigated.
Therefore, in accordance with Annex VIII, Column 1, Section 8.8.1, of Regulation (EC) No 1907/2006 and with Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance (ECHA, 2014), assessment of the toxicokinetic behaviour of calcium bis (dihydrogenorthophosphate) (MCP) is conducted to the extent that can be derived from the relevant available information. This comprises a qualitative assessment of the physicochemical and toxicological properties according to Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance (ECHA, 2014).
Calcium bis (dihydrogenorthophosphate) is a solid at 20°C with a molecular weight of 235 g/mol and a water solubility of 93900 mg/L.
ABSORPTION
Oral
No specific data regarding oral absorption of calcium bis (dihydrogenorthophosphate) (MCP) were found. ECHA guidance suggests that absorption is considered favourable for substances with a molecular weight (MW) below 500 g/mol (ECHA, 2014). Thus, the MW (235 g/mol) might be indicative of absorption. For a substance to be absorbed efficiently from the gastrointestinal tract it must be in solution. A recent study report determined the water solubility of MCP to be 93900 mg/L at neutral conditions, which shows it is soluble in water. No log oil/water partition coefficient (logP) value was determined as MCP is an inorganic phosphate, therefore the passive passage across biological membranes will be negligible. However as calcium and phosphate are key elements in various cellular processes their import and export over cell membranes is regulated via pore systems and ion transporters and are usually tightly regulated. Looking at the acute oral toxicity study, mortality at high dosage and piloerection, diarrhea and moderate depression were the clinical signs observed in rats following a single oral dose of MCP. Taking together, MCP is absorbed to a certain extent via the oral route. In the absence of specific data to the contrary, a default value of 100% is suggested.
Dermal
ECHA guidance suggests that absorption is considered favourable for substances with a MW below 100 g/mol (ECHA, 2014). Therefore, the MW (235 g/mol) suggests dermal absorption is possible. For a compound to penetrate the stratum corneum, it must be sufficiently water soluble i. e. above 1 mg/L (ECHA, 2014). The aqueous solubility of MCP (93900 mg/L) indicates that dermal absorption will be moderate to high (ECHA, 2014). In addition, as the test substance is a solid, hindered dermal absorption has to be considered as dry particulates first have to dissolve into the surface moisture of the skin before uptake via the skin is possible (ECHA, 2014). Moreover, the in vitro skin irritation studies performed with MCP showed no irritating effects. Overall, taking into account the physicochemical properties of MCP and available toxicological data the dermal absorption potential of the substance is anticipated to be low. QSAR analysis of MCP suggest a moderate dermal absorption rate with an absorption potential of 50% which is also recommended.
Inhalation
According to ECHA guidance (ECHA 2014), particles with aerodynamic diameters below 100 µm have the potential to be inhaled. In a recent study report, the mean mass median aerodynamic diameter of MCP was measured up to 3.03 µm. Therefore, MCP particles can be inhaled and, since they are below 15 µm, may reach the alveolar region of the respiratory tract (ECHA, 2014). Also, the substance is not lipophilic therefore would not have the potential to be absorbed directly across the respiratory tract epithelium. However, its nature as physiological substance (calcium cations and phosphate anions) will probably lead to some absorption via the respiratory tract. Non-resorbed particles in the oral-nasal cavity, the airways and the lungs will be transferred to the gastrointestinal tract with the mucus and absorbed there. Therefore absorption from the gastrointestinal tract will contribute to the total systemic burden of the substance that is inhaled. On this basis, a default of 100% is proposed.
DISTRIBUTION/METABOLISM
No data were found regarding the distribution and metabolism for MCP. Looking at the physicochemical parameters of MCP (MW > 100 g/mol, inorganic, soluble) a wide tissue distribution is not assumed (ECHA, 2014). But the structure suggests MCP will ionise to phosphate anions and calcium species. Phosphate is dissolved as ions in blood. Calcium is partly dissolved as ions while about 50% is bound to albumin in blood. As both ions are indispensable to life their distribution is tightly regulated systemically as well as intra-cellular. Both ions are inorganic and stable to reduction or oxidation in biological systems. Phosphate is condensed to di and triphosphates (e. g. AMP, ADT, ATP). Calcium is complexed to important biological molecules (e. g. Ca: calmodulin, calbindin, etc.).
EXCRETION
Assuming homeostasis of these indispensable nutrients the same amount is excreted as taken up. Calcium and phosphate are generally excreted mainly via kidneys but also via faeces and sweat (varying for the specific ion).
References:
ECHA (2014). Guidance on information requirements and chemical safety assessment. Chapter R.7c: Endpoint specific guidance. Version 2.0, November 2014.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.